RS62100B1 - Postupak inaktivacije ksenoantigena u biološkim tkivima - Google Patents
Postupak inaktivacije ksenoantigena u biološkim tkivimaInfo
- Publication number
- RS62100B1 RS62100B1 RS20210866A RSP20210866A RS62100B1 RS 62100 B1 RS62100 B1 RS 62100B1 RS 20210866 A RS20210866 A RS 20210866A RS P20210866 A RSP20210866 A RS P20210866A RS 62100 B1 RS62100 B1 RS 62100B1
- Authority
- RS
- Serbia
- Prior art keywords
- biological tissues
- xenoantigens
- inactivating
- inactivating xenoantigens
- tissues
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3625—Vascular tissue, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Plant Substances (AREA)
- Prostheses (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB2015A006019A ITUB20156019A1 (it) | 2015-11-30 | 2015-11-30 | Metodo per l'inattivazione di xenoantigeni in tessuti biologici |
PCT/EP2016/078898 WO2017093147A1 (en) | 2015-11-30 | 2016-11-25 | Method for inactivating xenoantigens in biological tissues |
EP16801773.9A EP3383446B1 (en) | 2015-11-30 | 2016-11-25 | Method for inactivating xenoantigens in biological tissues |
Publications (1)
Publication Number | Publication Date |
---|---|
RS62100B1 true RS62100B1 (sr) | 2021-08-31 |
Family
ID=55485194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20210866A RS62100B1 (sr) | 2015-11-30 | 2016-11-25 | Postupak inaktivacije ksenoantigena u biološkim tkivima |
Country Status (19)
Country | Link |
---|---|
US (1) | US20180353647A1 (sr) |
EP (1) | EP3383446B1 (sr) |
JP (1) | JP7169645B2 (sr) |
KR (1) | KR20180090816A (sr) |
CN (1) | CN108367098B (sr) |
AU (1) | AU2016363536B2 (sr) |
BR (1) | BR112018011021B1 (sr) |
CA (1) | CA3006234A1 (sr) |
CU (1) | CU24631B1 (sr) |
DK (1) | DK3383446T3 (sr) |
ES (1) | ES2881603T3 (sr) |
IL (1) | IL259591B (sr) |
IT (1) | ITUB20156019A1 (sr) |
MX (1) | MX2018006577A (sr) |
PL (1) | PL3383446T3 (sr) |
RS (1) | RS62100B1 (sr) |
RU (1) | RU2754197C2 (sr) |
WO (1) | WO2017093147A1 (sr) |
ZA (1) | ZA201803786B (sr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201600115523A1 (it) * | 2016-11-16 | 2018-05-16 | Biocompatibility Innovation Srl | Metodo per l'inattivazione ed il controllo di avvenuta inattivazione di xenoantigeni in alimenti di origine animale, particolarmente per latte e derivati, e in alimenti di origine vegetale, particolarmente per succedanei di latte a base di soia e/o riso |
CA3138296A1 (en) * | 2019-05-22 | 2020-11-26 | Filippo Naso | Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices |
WO2024189407A1 (en) | 2023-03-14 | 2024-09-19 | Biocompatibility Innovation S.r.l. | A method for imparting antimicrobial properties to a synthetic substrate |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001054722A1 (en) | 2000-01-25 | 2001-08-02 | Board Of Regents Of The University Of Nebraska | Pre-transplant accommodated organs resistant to anti-donor immunity |
US20040153145A1 (en) * | 2002-11-26 | 2004-08-05 | Clemson University | Fixation method for bioprostheses |
NZ549953A (en) * | 2004-03-17 | 2010-11-26 | Revivicor Inc | Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
AU2006315195B2 (en) * | 2005-11-10 | 2011-07-14 | Hill's Pet Nutrition, Inc. | Compositions and methods for improving skin health and pelage quality |
US20070282422A1 (en) * | 2006-05-10 | 2007-12-06 | Cook Incorporated | Medical devices and methods for local delivery of elastin-stabilizing compounds |
CN101366979B (zh) * | 2008-09-03 | 2012-08-29 | 陕西瑞盛生物科技有限公司 | 一种组织补片及其制备方法 |
FR2947456B1 (fr) * | 2009-07-06 | 2012-03-09 | Univ Bordeaux 1 | Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain |
IL210162A0 (en) * | 2010-12-21 | 2011-03-31 | Omrix Biopharmaceuticals | Viral inactivated platelet extract, use and preparation thereof |
EP2709711B8 (en) | 2011-05-18 | 2017-03-22 | Vatrix Medical, Inc. | Coated balloons for blood vessel stabilization |
RU2495928C2 (ru) * | 2012-01-30 | 2013-10-20 | Сергей Юрьевич Лешков | Средство для стимуляции синтеза белков теплового шока hsp 70 в клетках человека и животных; косметическое средство для стимуляции репаративных процессов; косметическое средство для снижения побочных эффектов агрессивных косметологических процедур; биологически активная добавка; пищевой продукт; способ снижения побочных эффектов агрессивных косметологических процедур |
ITPD20120029A1 (it) * | 2012-02-09 | 2013-08-10 | Alessandro Gandaglia | Metodo per la rilevazione di uno xenoantigene in tessuti fissati usati come sostituti bioprotesici |
US9283241B2 (en) * | 2012-07-10 | 2016-03-15 | Clemson University | Treatment to render implants resistant to diabetes |
US9795573B2 (en) | 2013-09-24 | 2017-10-24 | Clemson University | Multi-step connective tissue stabilization method and stabilized tissue formed thereby |
US11951078B2 (en) * | 2019-05-22 | 2024-04-09 | Biocompatibility Innovation S.r.l. | Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices |
-
2015
- 2015-11-30 IT ITUB2015A006019A patent/ITUB20156019A1/it unknown
-
2016
- 2016-11-25 MX MX2018006577A patent/MX2018006577A/es unknown
- 2016-11-25 JP JP2018546756A patent/JP7169645B2/ja active Active
- 2016-11-25 CN CN201680069993.5A patent/CN108367098B/zh active Active
- 2016-11-25 ES ES16801773T patent/ES2881603T3/es active Active
- 2016-11-25 DK DK16801773.9T patent/DK3383446T3/da active
- 2016-11-25 CA CA3006234A patent/CA3006234A1/en active Pending
- 2016-11-25 RS RS20210866A patent/RS62100B1/sr unknown
- 2016-11-25 CU CU2018000048A patent/CU24631B1/es unknown
- 2016-11-25 US US15/779,953 patent/US20180353647A1/en active Pending
- 2016-11-25 BR BR112018011021-3A patent/BR112018011021B1/pt active IP Right Grant
- 2016-11-25 AU AU2016363536A patent/AU2016363536B2/en active Active
- 2016-11-25 EP EP16801773.9A patent/EP3383446B1/en active Active
- 2016-11-25 KR KR1020187016622A patent/KR20180090816A/ko not_active Application Discontinuation
- 2016-11-25 RU RU2018123621A patent/RU2754197C2/ru active
- 2016-11-25 PL PL16801773T patent/PL3383446T3/pl unknown
- 2016-11-25 WO PCT/EP2016/078898 patent/WO2017093147A1/en active Application Filing
-
2018
- 2018-05-24 IL IL259591A patent/IL259591B/en unknown
- 2018-06-07 ZA ZA2018/03786A patent/ZA201803786B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3383446A1 (en) | 2018-10-10 |
CN108367098A (zh) | 2018-08-03 |
CN108367098B (zh) | 2021-06-11 |
IL259591B (en) | 2022-04-01 |
MX2018006577A (es) | 2018-09-05 |
RU2018123621A (ru) | 2020-01-09 |
CU24631B1 (es) | 2022-12-12 |
RU2754197C2 (ru) | 2021-08-30 |
DK3383446T3 (da) | 2021-07-26 |
BR112018011021A2 (pt) | 2018-11-21 |
US20180353647A1 (en) | 2018-12-13 |
JP7169645B2 (ja) | 2022-11-11 |
AU2016363536B2 (en) | 2021-04-01 |
RU2018123621A3 (sr) | 2020-04-10 |
PL3383446T3 (pl) | 2021-11-02 |
CA3006234A1 (en) | 2017-06-08 |
CU20180048A7 (es) | 2018-11-06 |
KR20180090816A (ko) | 2018-08-13 |
BR112018011021B1 (pt) | 2021-12-07 |
IL259591A (en) | 2018-07-31 |
ES2881603T3 (es) | 2021-11-30 |
ITUB20156019A1 (it) | 2017-05-30 |
EP3383446B1 (en) | 2021-04-28 |
JP2019503821A (ja) | 2019-02-14 |
AU2016363536A1 (en) | 2018-06-28 |
WO2017093147A1 (en) | 2017-06-08 |
ZA201803786B (en) | 2019-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201705673B (en) | Methods for treating skin | |
EP3137876C0 (en) | PERSONALIZED HAIR COLORING PROCESS | |
IL259992B (en) | Compounds for use in methods for treating hyperalgesia | |
HK1244217A1 (zh) | 用於治療蛋白質病的方法 | |
EP3354288C0 (en) | STERILIZATION DEVICE | |
PT3174563T (pt) | Enxerto de tecido | |
HK1243055A1 (zh) | 用於抗蠕蟲治療的化合物 | |
IL276577A (en) | Methods for treating cardiac injury | |
PL3075340T3 (pl) | Nożyce chirurgiczne do tkanki biologicznej | |
ZA201701426B (en) | Compounds for use in anthelminthic treatment | |
GB201420756D0 (en) | Improvements in tissue processing | |
ZA201800632B (en) | Method for treating diseases in plants | |
ZA201803786B (en) | Method for inactivating xenoantigens in biological tissues | |
IL252904A0 (en) | Methods and factors for treating diseases | |
SG11201700623YA (en) | Biological treatment method and biological treatment device | |
HUE047940T2 (hu) | Eritromelalgia kezelése | |
IL264600B (en) | A knife for use in medical treatment | |
IL254336A0 (en) | A new treatment method | |
SG11201803077UA (en) | Cell treatment apparatus | |
GB201416469D0 (en) | Apparatus for stimulating living tissue | |
HK1252261A1 (zh) | 醫療廢棄物容器的處理方法 | |
ZA201800752B (en) | Improved prosthesis for osteosynthesis | |
SG11201800356WA (en) | Biological treatment device | |
GB201704685D0 (en) | Biological methods | |
ZA201607027B (en) | Method for treating or enhancing muscle tissue |